Gertjan J L Kaspers
Overview
Explore the profile of Gertjan J L Kaspers including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
262
Citations
6068
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Centanni M, van de Velde M, Uittenboogaard A, Kaspers G, Karlsson M, Friberg L
Clin Pharmacokinet
. 2023 Dec;
63(2):197-209.
PMID: 38141094
Background: Vincristine-induced peripheral neuropathy (VIPN) is a common adverse effect of vincristine, a drug often used in pediatric oncology. Previous studies demonstrated large inter- and intrapatient variability in vincristine pharmacokinetics...
12.
Schwartz E, Rensen N, Steur L, Gemke R, van Eijkelenburg N, van der Sluis I, et al.
BMJ Open
. 2023 Oct;
13(10):e070804.
PMID: 37899146
Objectives: Health-related quality of life (HRQoL) is impaired in paediatric patients with acute lymphoblastic leukaemia (ALL). Over the past decades, ALL treatment has successfully been adjusted to the risk of...
13.
Uittenboogaard A, van den Berg M, Abbink F, Twisk J, van der Sluis I, van den Bos C, et al.
Cancer Med
. 2023 Sep;
12(19):19480-19490.
PMID: 37732486
Introduction: Vincristine is an integral component of treatment for children with cancer. Its main dose-limiting side effect is vincristine-induced peripheral neuropathy (VIPN). The VINCA trial was a randomized controlled trial...
14.
Sari N, Berbudi A, Susanah S, Reniarti L, Supriyadi E, Kaspers G, et al.
Asian Pac J Cancer Prev
. 2023 Aug;
24(8):2773-2780.
PMID: 37642064
Purpose: The asparaginase's (ASP) utility for ALL treatment is limited by neutralizing antibodies, which is problematic in countries whose access limited to alternative preparations. ASP antibody levels and activity was...
15.
Schoon S, Makamo N, Uittenboogaard A, Bernhardt M, Ozuah N, Kaspers G, et al.
Pediatr Blood Cancer
. 2023 Jul;
:e30531.
PMID: 37393425
Objectives: This systematic review provides an overview of the effect of undernutrition on the pharmacokinetics of chemotherapy in children with cancer. Methods: PubMed, Embase, and Cochrane were searched to identify...
16.
van Weelderen R, Wijnen N, Njuguna F, Klein K, Vik T, Olbara G, et al.
Cancer Rep (Hoboken)
. 2023 Jun;
6(8):e1849.
PMID: 37349659
Purpose: The Pediatric Oncology in Developing Countries (PODC) committee of the International Society of Pediatric Oncology (SIOP) published a pediatric acute myeloid leukemia (AML)-specific adapted treatment guideline for low- and...
17.
El-Khouly F, Haumann R, Breur M, Veldhuijzen van Zanten S, Kaspers G, Hendrikse N, et al.
Free Neuropathol
. 2023 Jun;
2.
PMID: 37284626
Diffuse intrinsic pontine glioma (DIPG) is a childhood brainstem tumor with a median overall survival of eleven months. Lack of chemotherapy efficacy may be related to an intact blood-brain barrier...
18.
Wijnen N, Koedijk J, Klein K, Luesink M, Goemans B, Zwaan C, et al.
Onco Targets Ther
. 2023 May;
16:297-308.
PMID: 37153641
Although survival in pediatric acute myeloid leukemia (AML) has increased considerably over the past decades, refractory disease and relapse rates remain high. Refractory and relapsed disease are difficult to treat,...
19.
Lemmen J, Njuguna F, Verhulst S, Vik T, Ket J, Kaspers G, et al.
Crit Rev Oncol Hematol
. 2023 Apr;
185:103981.
PMID: 37003444
Introduction: The number of children surviving cancer in Africa is increasing. Knowledge about late effects of survivors is lacking. Our study maps literature regarding late effects of childhood cancer survivors...
20.
van Weelderen R, Klein K, Harrison C, Jiang Y, Abrahamsson J, Arad-Cohen N, et al.
J Clin Oncol
. 2023 Mar;
41(16):2963-2974.
PMID: 36996387
Purpose: A previous study by the International Berlin-Frankfurt-Münster Study Group (I-BFM-SG) on childhood -rearranged (-r) AML demonstrated the prognostic value of the fusion partner. This I-BFM-SG study investigated the value...